Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease

• Main Authors: Suna Lahut (Author), Suzana Gispert (Author), Özgür Ömür (Author), Candan Depboylu (Author), Kay Seidel (Author), Jorge Antolio Domínguez-Bautista (Author), Nadine Brehm (Author), Hülya Tireli (Author), Karl Hackmann (Author), Caroline Pirkevi (Author), Barbara Leube (Author), Vincent Ries (Author), Kerstin Reim (Author), Nils Brose (Author), Wilfred F. den Dunnen (Author), Madrid Johnson (Author), Zsuzsanna Wolf (Author), Marc Schindewolf (Author), Wiebke Schrempf (Author), Kathrin Reetz (Author), Peter Young (Author), David Vadasz (Author), Achilleas S. Frangakis (Author), Evelin Schröck (Author), Helmuth Steinmetz (Author), Marina Jendrach (Author), Udo Rüb (Author), Ayşe Nazlı Başak (Author), Wolfgang Oertel (Author), Georg Auburger (Author)
• Format: Book
• Published: The Company of Biologists, 2017-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Parkinson's disease (PD) is a frequent neurodegenerative process in old age. Accumulation and aggregation of the lipid-binding SNARE complex component α-synuclein (SNCA) underlies this vulnerability and defines stages of disease progression. Determinants of SNCA levels and mechanisms of SNCA ne...